Dr. Ron King is a co-founder of BioAccel, a non-profit organization created to provide funding and business expertise to develop early stage life science technologies that drive local economic growth. Prior to starting BioAccel, Dr. King was the Vice President of Business and Strategic Partnerships at The Translational Genomics Research Institute (TGen) where he was responsible for alliance management, business development and technology commercialization. He has in depth experience in creating and launching novel programs designed to transform new technologies from research discoveries into useful products and business opportunities. He has held several senior level positions at the National Institutes of Health and has helped manage the development of several technology programs with the Human Genome Project, responsible for a team of over 300 scientists. Dr. King has extensive experience in academia, government and industry, involved in the formation and launch of over 10 biotech companies. Currently, Dr. King is the Sr. Director, Research Translation Programs at the University of California, Irvine Applied Innovation program. Dr. King holds a Ph.D. in Biochemistry and Pharmacology from the University of California, Los Angeles and Riverside. He holds an MBA from Arizona State University, and certifications and training from the Haas School of Business at the University of California, Berkeley.